InvestorsHub Logo

2times2

08/26/15 8:03 PM

#15718 RE: badguy3101 #15717

hello MODS...can someone sticky this (several ihubbers run into this article and posted here today

BullishSwag

08/27/15 9:45 AM

#15753 RE: badguy3101 #15717

MODS, PLEASE STICKY

2times2

08/27/15 2:06 PM

#15814 RE: badguy3101 #15717

where are the moderators; please sticky badguy's and other's find!!! thank you

Chugit

08/28/15 4:22 PM

#15877 RE: badguy3101 #15717

Eyes are all over this. Get Ready. Great Article.

Chugit

09/04/15 2:01 PM

#16202 RE: badguy3101 #15717

This guy here knows what he is talking about. Seeking Alpha:

"Likewise in the small cap space, Progressive Care Inc. (OTCPK:RXMD) through its subsidiary Pharmco LLC has realized incredible growth over the last 18 months through largely increasing the reach within the South Florida market and achieving quarter over quarter increases in prescription volume. The company ended 2014 with revenues of $11 million and after the first two quarters of operation is on pace to top that by the end of 2015. In a recent independent analyst report, not only has the stock received a buy rating and short term price target of $0.03 (233% above Friday's closing pps) but the analyst also cited several key reasons for growth. These included healthcare consolidation as well as the region itself, Florida being one of the top five med-tech job producers in the country.

During the three months ended June 30, 2015, prescriptions counts reached a record high of approximately 43,000 fills, which represents a year-over-year increase of 11%. In addition to this, Progressive reported a net revenue increase of 18% year-over-year for the six months ended June 30, 2015 from approximately $5.40 million to approximately $6.40 million. From a loss of $270,000 for the first two quarters of 2014, the company reached profitability in 2015 of approximately $85,000 and improved cash on hand realizing an increase to $282,486 from the beginning of the year. These numbers are traditionally not something you see with pink sheet companies or stocks trading at these levels.

Over the last 8 months the stock has seen prices spike as high as $0.08 and $0.049 in more recent weeks. The $0.03 target short-term appears to be attainable with the major risk being the company's current debt reduction mechanism in place. Though this has been a source of dilution, Progressive has not let it go unnoticed and has kept the public updated as much as possible. As of the last PR that included information on such instances, the company had extinguished over $600,000 through its 3(a)(10) transaction. Being that this was stated in early July, it would stand to reason that this number would be greatly different taking into account the total amount of volume the stock has seen especially during recent trading sessions."